JPMorgan Assumes HealthEquity, Inc (HQY) at Overweight
Get Alerts HQY Hot Sheet
Rating Summary:
19 Buy, 2 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 1
Join SI Premium – FREE
JPMorgan assumes coverage on HealthEquity, Inc (NASDAQ: HQY) with a Overweight rating and a price target of $69.00.
Analyst Anne Samuel assumes coverage and comments "We see the primary driver of growth in Healthcare IT as the shift towards value-based care necessitating increased clinical data collection and analysis as payment moves towards an outcomes-based model. Following a period of stimulus spurred by the HITECH act, growth has sputtered in the core EHR market with providers taking a “wait and see” approach to further spending absent a government carrot."
For an analyst ratings summary and ratings history on HealthEquity, Inc click here. For more ratings news on HealthEquity, Inc click here.
Shares of HealthEquity, Inc closed at $66.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Starts Immunovant (IMVT) at Outperform, 'expect the execution to unlock considerable value'
- Oppenheimer Starts Xeris Pharmaceuticals (XERS) at Outperform, 'successful commercial execution will continue to drive top-line growth'
- Korro Bio Inc. (KRRO) PT Raised to $90 at RBC Capital
Create E-mail Alert Related Categories
Analyst Comments, New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!